10x Genomics: Leerink Partners raises target price to $90 from $40
TXG•Leerink Partners raised its target price for 10x Genomics to $90 from $40.
Related News
Arrowhead Pharmaceuticals to host R&D webinar on ARO-MAPT interim Phase 1/2a data
ARWR•
Cintas Corporation: Argus Research raises target price to $240 from $230
CTAS•
OCAL Financial targets growth with asset-light vehicle sourcing model, zero standing inventory
KAR•
H.B. Fuller: Deutsche Bank cuts target price to $62 from $72
FUL•
Cognition Therapeutics schedules FDA meeting to align on Phase 3 DLB trial endpoints
CGTX•